HTB homepage • Conference reports • Articles by subject • Subscribe April 2002 Contents Conference reports 9th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Februrary 24-28 2002 Study results shed light on cardiovascular risks: role of antiretrovirals and metabolism of lipids and sugars Switch to abacavir improves lipoatrophy Potential use of niacin to reduce intra-abdominal fat Further benefits shown with New-Fill for facial atrophy Lipodystrophy associated with lower CD4+ T cell counts Treatment interruptions Analysis of cells from long term non-progressors points the way to using vaccines and STIs to restore immune response to HIV Symposium on T cell turnover and thymic function New drugs: perhaps some genuine excitement this time T20 and beyond: inhibition of HIV attachment and fusion at the 9th CROI Pharmacogenetics predict abacavir hypersensitivity Pregnancy: growing body of evidence supports treating maternal disease Peripheral neuropathy update Treatment access South Africa finds 1 billion Rand to treble HIV budget, after Mandela confronts Mbeki Side effects Leptin reverses lipodystrophy in diabetic patients Coinfections and complications Increased selenium intake may protect HIV positive patients from mycobacterial disease Basic science and immunology Passive transfer of scrub typhus plasma linked to reduced HIV viral load and clinical improvement HIV protease inhibitors have potent antiangiogenesis, antitumor effects Other news Rivals Robert Gallo and Luc Montagnier launch joint vaccine project Abbott announces therapeutic drug monitoring scheme for lopinavir/r Johnson and Johnson to acquire Tibotec-Virco PRO 542: reduced viral loads in patients failing conventional therapy Researchers uncover possible drug approach to attack HIV-infected cells Entry criteria changed for Optima study and treatment options for salvage therapy IL-2 still available in UK in ESPRIT study, safety management guidelines expanded On the web Further Retroconference reports and data on the web Controlling PI resistance like a switch: MDR1 and p-glycoprotein How do proteins cause drug resistance? HE2000 PDFs Volume 3 Number 3 April 2002 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
